Souhaitez-vous accéder aux communiqués récents ?

CAPHRA believes that India risks making it harder for people who smoke to quit if they initiate a restriction on nicotine gums and lozenges.

CAPHRA supports Bangladesh’s review of its sweeping 2025 ban on vaping and other emerging nicotine products as a chance to save lives.

CAPHRA reminds governments in Asia Pacific that they do not need to choose between sovereignty and human rights in public health policy.

Policymakers must draw a clear line between criminally adulterated vape products and regulated nicotine alternatives intended for adult smokers.

CAPHRA has developed a policy framework urging governments to implement tobacco harm reduction (THR) as a regulated, health-led pathway.

CAPHRA strongly criticises the World Health Organization’s FCTC Campaign "Myths vs Facts" as misinformation.

CAPHRA urges governments to regulate oral nicotine: protect youth, set product standards, and keep markets controllable through enforceable rules.

The primary problem is not enforcement capacity. It is policy design. The current policy settings are driving the growth of an illicit market.

This white paper exposes how the World Health Organization's FCTC has been captured by NGOs undermining the treaty's credibility.

The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is celebrating the success of “Asia Day” at GoodCOP 2.0